Welcome to Our Medtech Talk Podcast Channel

Too often we define the Medtech sector by the number of dollars raised, IPOs helped or companies sold. But the focus neglects the very foundation of the sector - the People. Join the Medtech Talk Podcast each week to hear from entrepreneurs, investors and executives who spend their days developing the tools that make sick people well and health care more efficient.

Trigg: Outset’s Tablo Could Create `Boutique’ Dialysis

March 15, 2016

Outset Medical CEO Leslie Trigg brings a career of success in medtech into a new approach to dialysis. Tablo, a sleek device, could enable dialysis companies an easier, cheaper way of providing dialysis to patients.

Leslie Trigg

President & CEO

Outset Medical

Before becoming Outset’s President and CEO, Leslie was the company’s Chief Operating Officer and also served as an Executive-in-Residence at Warburg Pincus. Prior to Outset, she was Executive Vice President at Lutonix. Before joining Lutonix, Leslie served as Chief Business Officer of AccessClosure. Earlier in her career, she was Vice President, Marketing for FoxHollow Technologies, helping to architect the strategy and commercial infrastructure that led to a successful IPO and subsequent acquisition by ev3/Covidien. Leslie’s management experience also includes senior leadership positions at Cytyc Corporation and breast cancer diagnostics company Pro-Duct Health, Inc., which was acquired by Cytyc. She began her medical device career at Guidant Corporation in new product global marketing. In addition to her role at Outset, Leslie is also a board member of Cardiovascular Systems, Inc. (NASDAQ: CSII). She received her undergraduate degree from Northwestern University and her MBA from the Haas School of Business, UC Berkeley.